84.53 USD
-1.17 (-1.37%)
84.53 USD
0 (0%)
LMAT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties. LMAT is not valued too expensively and it also shows a decent growth rate. This makes LMAT very considerable for quality investing!
1. Profitability
1.1 Basic Checks
LMAT had positive earnings in the past year.
In the past year LMAT had a positive cash flow from operations.
Each year in the past 5 years LMAT has been profitable.
LMAT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of LMAT (8.92%) is better than 91.53% of its industry peers.
The Return On Equity of LMAT (14.08%) is better than 90.48% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.43%, LMAT belongs to the top of the industry, outperforming 87.30% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LMAT is in line with the industry average of 8.81%.
The 3 year average ROIC (8.26%) for LMAT is below the current ROIC(8.43%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROIC | 8.43% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
Looking at the Profit Margin, with a value of 22.14%, LMAT belongs to the top of the industry, outperforming 94.18% of the companies in the same industry.
In the last couple of years the Profit Margin of LMAT has grown nicely.
With an excellent Operating Margin value of 25.71%, LMAT belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
LMAT's Operating Margin has improved in the last couple of years.
The Gross Margin of LMAT (70.97%) is better than 78.84% of its industry peers.
LMAT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
LMAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LMAT has been increased compared to 1 year ago.
The number of shares outstanding for LMAT has been increased compared to 5 years ago.
LMAT has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 7.24 indicates that LMAT is not in any danger for bankruptcy at the moment.
The Altman-Z score of LMAT (7.24) is better than 85.71% of its industry peers.
The Debt to FCF ratio of LMAT is 2.54, which is a good value as it means it would take LMAT, 2.54 years of fcf income to pay off all of its debts.
LMAT has a Debt to FCF ratio of 2.54. This is amongst the best in the industry. LMAT outperforms 85.71% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that LMAT is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.44, LMAT perfoms like the industry average, outperforming 46.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Altman-Z | 7.24 |
ROIC/WACC0.98
WACC8.57%
2.3 Liquidity
A Current Ratio of 13.58 indicates that LMAT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 13.58, LMAT belongs to the top of the industry, outperforming 97.88% of the companies in the same industry.
LMAT has a Quick Ratio of 11.45. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT has a Quick ratio of 11.45. This is amongst the best in the industry. LMAT outperforms 95.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 19.67% over the past year.
The Earnings Per Share has been growing by 17.13% on average over the past years. This is quite good.
Looking at the last year, LMAT shows a quite strong growth in Revenue. The Revenue has grown by 13.07% in the last year.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.10% yearly.
LMAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.65% yearly.
EPS Next Y27.73%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 38.60, which means the current valuation is very expensive for LMAT.
Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than 70.90% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.49, LMAT is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 32.03, the valuation of LMAT can be described as expensive.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than 72.49% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, LMAT is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.6 | ||
| Fwd PE | 32.03 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 76.19% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LMAT is valued cheaper than 80.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.96 | ||
| EV/EBITDA | 19.74 |
4.3 Compensation for Growth
LMAT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of LMAT may justify a higher PE ratio.
LMAT's earnings are expected to grow with 14.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.39
PEG (5Y)2.25
EPS Next 2Y16.63%
EPS Next 3Y14.06%
5. Dividend
5.1 Amount
With a yearly dividend of 0.93%, LMAT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.74, LMAT pays a better dividend. On top of this LMAT pays more dividend than 93.12% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.93% |
5.2 History
On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
LMAT pays out 32.20% of its income as dividend. This is a sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.2%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
84.53
-1.17 (-1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.15%
Inst Owner Change-3.91%
Ins Owners7.89%
Ins Owner Change-5.69%
Market Cap1.92B
Revenue(TTM)240.87M
Net Income(TTM)53.34M
Analysts78.82
Price Target106.42 (25.9%)
Short Float %5.62%
Short Ratio7.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.93% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP32.2%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.59%
Min EPS beat(2)3.81%
Max EPS beat(2)7.38%
EPS beat(4)2
Avg EPS beat(4)0.79%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.68%
EPS beat(12)9
Avg EPS beat(12)4.66%
EPS beat(16)9
Avg EPS beat(16)-0.71%
Revenue beat(2)1
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.28%
PT rev (3m)-0.42%
EPS NQ rev (1m)3.93%
EPS NQ rev (3m)4.07%
EPS NY rev (1m)6.5%
EPS NY rev (3m)6.42%
Revenue NQ rev (1m)-1.4%
Revenue NQ rev (3m)-2.16%
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-0.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.6 | ||
| Fwd PE | 32.03 | ||
| P/S | 7.96 | ||
| P/FCF | 28.96 | ||
| P/OCF | 26.17 | ||
| P/B | 5.06 | ||
| P/tB | 6.82 | ||
| EV/EBITDA | 19.74 |
EPS(TTM)2.19
EY2.59%
EPS(NY)2.64
Fwd EY3.12%
FCF(TTM)2.92
FCFY3.45%
OCF(TTM)3.23
OCFY3.82%
SpS10.62
BVpS16.7
TBVpS12.4
PEG (NY)1.39
PEG (5Y)2.25
Graham Number28.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROCE | 10.97% | ||
| ROIC | 8.43% | ||
| ROICexc | 21.47% | ||
| ROICexgc | 38.36% | ||
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% | ||
| FCFM | 27.5% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 68.51% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.46% | ||
| Profit Quality | 124.17% | ||
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 | ||
| Altman-Z | 7.24 |
F-Score5
WACC8.57%
ROIC/WACC0.98
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
EPS Next Y27.73%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
EBIT growth 1Y24.85%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year45.26%
EBIT Next 3Y22.27%
EBIT Next 5YN/A
FCF growth 1Y189.96%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y143.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
Can you provide the valuation status for LEMAITRE VASCULAR INC?
ChartMill assigns a valuation rating of 5 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 38.6 and the Price/Book (PB) ratio is 5.06.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 27.73% in the next year.